Pharmacologic therapy for type 2 diabetes mellitus

Ann Intern Med. 2000 Jul 4;133(1):73-4. doi: 10.7326/0003-4819-133-1-200007040-00016.
No abstract available

Publication types

  • Letter

MeSH terms

  • Algorithms
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Approval
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Pioglitazone
  • Rosiglitazone
  • Thiazoles / therapeutic use
  • Thiazolidinediones*
  • United States
  • United States Food and Drug Administration

Substances

  • Hypoglycemic Agents
  • Thiazoles
  • Thiazolidinediones
  • Rosiglitazone
  • Pioglitazone